14. Global Rank 13 Brand 2012
Market Size: 5.1 Billion US$
Growth: 9.9%
Generic:
Tiotropium Bromide
Major Indication:
Bronchospasm in people with
bronchitis, emphysema, or COPD
15. Global Rank 14 Brand 2012
Market Size: 5.1 Billion US$
Growth: (60.7)
Generic:
Atorvastatin
Major Indication:
Lipid lowering Agent
16. Global Rank 15 Brand 2012
Market Size: 5.0 Billion US$
Growth: 9.0%
Generic:
Trastuzumab
Major Indication:
Breast Cancer
17. Global Rank 16 Brand 2012
Market Size: 4.7 Billion US$
Growth: (25.2%)
Generic:
Montelukast
Major Indication:
Asthmatic Inflammation